Search results
21 sie 2018 · The USPSTF found convincing evidence that screening with cervical cytology alone, primary testing for high-risk HPV types (hrHPV testing) alone, or in combination at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer.
21 sie 2018 · Screening with cervical cytology alone, primary testing for hrHPV alone, or both at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer. Clinicians should focus on ensuring that women receive adequate screening, appropriate evaluation of abnormal results, and indicated treatment, regardless of which ...
Screening with cervical cytology alone, primary testing for hrHPV alone, or both at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer. Clinicians should focus on ensuring that women receive adequate screening,
21 sie 2018 · The goal of screening for cervical cancer is to catch cervical cancer (or precancer) early; these cases are more treatable and curable than advanced cancer. There is good evidence that the Pap and HPV tests are good at finding cancer and precancerous cells.
Screening aims to identify high-grade precancerous cervical lesions to prevent development of cervical cancer and early-stage asymptomatic invasive cervical cancer. High-grade lesions may be treated with ablative and excisional therapies, including cryotherapy, laser ablation, loop excision, and cold knife conization.
Links and resources related to cervical screening, management, and colposcopy guidelines and recommendations. USPSTF Screening Guidelines. ASCCP endorses the United States Preventative Services Task Force (USPSTF) cervical cancer screening guidelines. View Guidelines.
15 lut 2019 · The USPSTF recommends screening for cervical cancer every 3 years with cervical cytology alone in women aged 21 to 29 years.
